Inactive Instrument

Highlights Theradiag

Equities

ALTER

FR0004197747

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Biosynex: merger with Theradiag completed	Dec. 18	CF
Theradiag SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21	CI
Theradiag SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Biosynex SA completed the acquisition of additional 46.52% stake in Theradiag SA for €21.6 million.	23-01-30	CI
Biosynex: takeover bid reopened for Theradiag shares	23-01-18	CF
Theradiag: takeover bid reopened on January 18	23-01-17	CF
Biosynex: successful takeover bid for Theradiag	23-01-16	CF
Theradiag: over 2.8 million shares tendered to the takeover bid	23-01-16	CF
Biosynex SA completed the acquisition of 40% stakes in Theradiag SA.	23-01-11	CI
Theradiag : News releases during takeover bids / Takeover bids Other news releases	22-09-23	PU
French Diagnostics Company Biosynex Offers to Take Over Theradiag	22-09-23	MT
Biosynex SA bid to acquire remaining 74.93% stakes in Theradiag SA.	22-09-22	CI
Theradiag SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics	22-06-08	CI
Theradiag Announces the Launch of ez-Track, A Point-Of-Care Testing Solution for Therapeutic Drug Monitoring	22-05-31	CI
THERADIAG Announces the Launch of Two New i-Tracker® Kits	22-05-19	CI
Theradiag SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Theradiag Signs PCR Test Distribution Agreement With Biosynex	22-01-13	MT
Theradiag Announces Signing of A Distribution Agreement with Biosynex of Their AMPLIQUICK SARS-CoV-2 PCR Test	22-01-13	CI
THERADIAG Announces the Launch of 4 New i-Tracker? Kits and the Validation of a New Parameter in the United States	21-12-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Theradiag

Equities

ALTER

FR0004197747

Highlights

Filters